BACHRODT AMY (SVP, Finance) sold 16.2% of their position (2.50K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $73.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/2/2026ACC: 0002050422-26-000012
Officer· SVP, Finance
Since Mar 2026
-2.50K
Net shares
Net seller
$73.6K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
2.50K acquired · 5K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+2.50K
Price / share
$10.42
Trade value
$26.05K
% of position
19.3%
4/1/2026
12.96K→15.46K
Common Stock
Direct
Shares
−2.20K
Price / share
$29.32
Trade value
$64.51K
% of position
14.2%
4/1/2026
15.46K→13.27K
Common Stock
Direct
Shares
−300.00
Price / share
$30.34
Trade value
$9.10K
% of position
2.3%
4/1/2026
13.27K→12.96K
Total
Net shares
+0.00
Net value
-$47.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | M · Option Exercise | +2.50K | $10.42 | $26.05K | 19.3% | 12.96K | 15.46K |
| Common Stock Direct | 4/1/2026 | S · Sale | −2.20K | $29.32 | $64.51K | 14.2% | 15.46K | 13.27K |
| Common Stock Direct | 4/1/2026 | S · Sale | −300.00 | $30.34 | $9.10K | 2.3% | 13.27K | 12.96K |
| Total | +0.00 | -$47.56K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.50K shares
Shares
−2.50K
Strike price
10.42
Held after
33.83K
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock2.50K shares | 4/1/2026 | M · Option Exercise | −2.50K | 10.42 | — | 33.83K |